Ocugen, Inc. (OCGN)
NASDAQ: OCGN · IEX Real-Time Price · USD
1.345
-0.045 (-3.24%)
May 2, 2024, 9:59 AM EDT - Market open

Ocugen Revenue

In the year 2023, Ocugen had annual revenue of $6.04M with 142.60% growth. Revenue in the quarter ending December 31, 2023 was $6.04M with 142.60% year-over-year growth.

Revenue (ttm)
$6.04M
Revenue Growth
+142.60%
P/S Ratio
59.26
Revenue / Employee
$92,862
Employees
65
Market Cap
346.11M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20236.04M3.55M142.60%
Dec 31, 20222.49M--
Dec 31, 20210--
Dec 31, 202043.00K--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Dec 31, 20140--
Dec 31, 20130--
Dec 31, 201226.00K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Health Catalyst 295.94M
Harrow Health 130.19M
Heron Therapeutics 127.04M
Esperion Therapeutics 116.33M
CytomX Therapeutics 101.21M
Precigen 6.23M
Revenue Rankings